The drugmaker AstraZeneca, which announced big job cuts Monday in research and development, said Thursday morning that it was would lay off 2,300 more people from sales and administrative departments over the next three years throughout its worldwide operation.
AstraZeneca has facilities in Wilmington and Newark, Del. A company spokesman declined to specify the immediate local impact.
The spokesman said that the majority of the 2,300 workers had been notified or soon would be, and that those people were largely in sales in Europe. The rest of the cuts will be determined over the next three years. The company had not decided which people, departments, or locations would be affected, he said.